Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Diamorphine pharmacokinetics and conversion factor estimates for intranasal diamorphine in paediatric breakthrough pain:systematic review.

< BACK TO ARCHIVE


Papers: 19 Feb 2022 - 25 Feb 2022


2022 Feb 19


BMJ Support Palliat Care


http://www.ncbi.nlm.nih.gov/pubmed/35184039?dopt=Abstract

Diamorphine pharmacokinetics and conversion factor estimates for intranasal diamorphine in paediatric breakthrough pain:systematic review.

Authors

Diamorphine pharmacokinetics and conversion factor estimates for intranasal diamorphine in paediatric breakthrough pain:systematic review.
Gastine S, Morse JD, Leung M T, Wong I C K, Howard RF, Harrop E, Liossi C, Standing JF, Jassal S S, Hain RD, Skene S, Oulton K, Law SL, Quek WT, Anderson BJ
BMJ Support Palliat Care. 2022 Feb 19.
PMID: 35184039.

Abstract

Intranasal diamorphine is a potential treatment for breakthrough pain but few paediatric data are available to assist dose estimation.
Read This Paper